Company · CIK 0001367644 · SIC 2834 — Pharmaceutical Preparations · NYSE
Emergent BioSolutions Inc. · EBS
Insider activity reported against this company. All insider holders · Files at: APVO. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2016 AForm 4 → | Mar 3, 9:20 am EST | Adam HaveyEVP, Biodefense Divison | 7,759 | — | — | 48,835 | — | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 9:20 am EST | Robert KramerEVP, Corporate Services Divisi | 14,780 | — | — | 84,659 | — | plan? |
| Mar 1, 2016 AForm 4 → | Mar 3, 9:19 am EST | Daniel Abdun-NabiPresident & CEO, Director | 35,471 | — | — | 220,839 | — | plan? |
| Jan 4, 2016 SForm 4 → | Jan 6, 10:24 am EST | Sue BaileyDirector | 11,520 | $38.79 | $446,890 | 28,500 | −28.8% | plan? |
| Jan 4, 2016 MForm 4 → | Jan 6, 10:24 am EST | Sue BaileyDirector | 11,520 | $15.37 | $177,091 | 31,380 | — | plan? |
| Dec 30, 2015 SForm 4 → | Jan 4, 2016, 3:02 pm EST | Ronald RichardDirector | 21,600 | $40.00 | $864,000 | 13,733 | −61.1% | plan? |
| Dec 30, 2015 MForm 4 → | Jan 4, 2016, 3:02 pm EST | Ronald RichardDirector | 21,600 | $8.43 | $182,088 | 35,333 | — | plan? |
| Dec 23, 2015 SForm 4 → | Dec 28, 2:20 pm EST | Daniel Abdun-NabiPresident & CEO, Director | 63,209 | $39.06 | $2,468,633 | 185,368 | −25.4% | plan? |
| Dec 23, 2015 MForm 4 → | Dec 28, 2:20 pm EST | Daniel Abdun-NabiPresident & CEO, Director | 63,209 | $18.90 | $1,194,650 | 208,223 | — | plan? |
| Dec 15, 2015 FMForm 4 → | Dec 17, 3:23 pm EST | Daniel Abdun-NabiPresident & CEO, Director | 6,781 | $29.49 | $199,996 | 185,368 | — | plan? |
| Nov 19, 2015 SForm 4 → | Nov 19, 9:03 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 17,871 | $37.50 | $670,163 | 1,852,284 | −0.96% | plan? |
| Nov 19, 2015 MForm 4 → | Nov 19, 9:03 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 27,900 | $18.90 | $527,310 | 1,870,155 | — | plan? |
| Nov 13, 2015 SForm 4 → | Nov 17, 5:15 pm EST | Barry LabingerEVP, Biosciences Div. | 3,376 | $36.50 | $123,224 | 25,182 | −11.8% | plan? |
| Nov 13, 2015 SForm 4 → | Nov 16, 8:02 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 13,013 | $36.50 | $474,975 | 1,842,255 | −0.70% | plan? |
| Nov 13, 2015 MForm 4 → | Nov 16, 8:02 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 20,000 | $18.90 | $378,000 | 1,855,268 | — | plan? |
| Nov 11, 2015 FMForm 4 → | Nov 13, 4:49 pm EST | Barry LabingerEVP, Biosciences Div. | 31,233 | $23.89 | $746,001 | 28,558 | — | plan? |
| Nov 11, 2015 SForm 4 → | Nov 13, 4:49 pm EST | Barry LabingerEVP, Biosciences Div. | 36,126 | $35.64 | $1,287,586 | 30,229 | −54.4% | plan? |
| Nov 9, 2015 SForm 4 → | Nov 10, 7:04 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 13,225 | $35.50 | $469,488 | 1,835,268 | −0.72% | plan? |
| Nov 9, 2015 MForm 4 → | Nov 10, 7:04 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 20,000 | $18.90 | $378,000 | 1,848,493 | — | plan? |
| Nov 6, 2015 SForm 4 → | Nov 6, 7:36 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 13,450 | $34.50 | $464,025 | 1,828,493 | −0.73% | plan? |
| Nov 6, 2015 MForm 4 → | Nov 6, 7:36 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 20,000 | $18.90 | $378,000 | 1,841,943 | — | plan? |
| Nov 4, 2015 FForm 4 → | Nov 6, 11:49 am EST | Robert KramerEVP, Corporate Services Div | 1,234 | $33.53 | $41,376 | 69,879 | — | plan? |
| Nov 3, 2015 SForm 4 → | Nov 4, 12:20 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 13,689 | $33.50 | $458,582 | 1,821,943 | −0.75% | plan? |
| Nov 3, 2015 MForm 4 → | Nov 4, 12:20 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 20,000 | $18.90 | $378,000 | 1,835,632 | — | plan? |
| Sep 11, 2015 SForm 4 → | Sep 15, 3:28 pm EDT | Sue BaileyDirector | 6,080 | $32.37 | $196,797 | 28,500 | −17.6% | plan? |
| Sep 11, 2015 MForm 4 → | Sep 15, 3:28 pm EDT | Sue BaileyDirector | 6,080 | $8.68 | $52,786 | 33,140 | — | plan? |
| Aug 13, 2015 SForm 4 → | Aug 14, 9:29 am EDT | George A JoulwanDirector | 7,200 | $34.72 | $249,984 | 19,500 | −27.0% | plan? |
| Aug 13, 2015 MForm 4 → | Aug 14, 9:29 am EDT | George A JoulwanDirector | 7,200 | $17.51 | $126,072 | 26,700 | — | plan? |
| Aug 13, 2015 SForm 4 → | Aug 13, 2:29 pm EDT | Ronald RichardDirector | 4,922 | $36.00 | $177,192 | 13,733 | −26.4% | plan? |
| Aug 10, 2015 SForm 4 → | Aug 10, 6:21 pm EDT | Fuad El-HibriChairman, Director, 10% Owner | 30,000 | $35.50 | $1,065,000 | 1,815,632 | −1.63% | plan? |
| Aug 6, 2015 SForm 4 → | Aug 7, 6:49 pm EDT | Fuad El-HibriChairman, Director, 10% Owner | 29,766 | $34.50 | $1,026,927 | 1,845,632 | −1.59% | plan? |
| Jul 20, 2015 SForm 4 → | Jul 22, 4:59 pm EDT | Fuad El-HibriChairman, Director, 10% Owner | 234 | $34.50 | $8,073 | 1,875,398 | −0.01% | plan? |
| Jul 13, 2015 SForm 4 → | Jul 13, 4:06 pm EDT | Ronald RichardDirector | 4,922 | $34.00 | $167,348 | 18,655 | −20.9% | plan? |
| Jun 29, 2015 SForm 4 → | Jul 1, 1:51 pm EDT | Ronald RichardDirector | 4,923 | $32.76 | $161,277 | 23,577 | −17.3% | plan? |
| Jun 24, 2015 MForm 4 → | Jun 26, 2:41 pm EDT | Adam HaveyEVP, Biodefense Divison | 10,238 | $18.90 | $193,498 | 41,076 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 22, 5:45 pm EDT | Fuad El-HibriChairman, Director, 10% Owner | 74,564 | $32.60 | $2,431,048 | 1,875,632 | −3.82% | plan? |
| Jun 16, 2015 SForm 4 → | Jun 17, 4:02 pm EDT | Louis W SullivanDirector | 13,457 | $31.32 | $421,541 | 28,500 | −32.1% | plan? |
| Jun 16, 2015 MForm 4 → | Jun 17, 4:02 pm EDT | Louis W SullivanDirector | 13,457 | $10.28 | $138,338 | 41,957 | — | plan? |
| Jun 15, 2015 SForm 4 → | Jun 17, 3:58 pm EDT | Adam HaveyEVP, Biodefense Divison | 36,298 | $31.55 | $1,145,053 | 30,838 | −54.1% | plan? |
| Jun 15, 2015 MForm 4 → | Jun 17, 3:58 pm EDT | Adam HaveyEVP, Biodefense Divison | 25,692 | $15.11 | $388,238 | 51,217 | — | plan? |
| Jun 11, 2015 SForm 4 → | Jun 15, 5:31 pm EDT | Fuad El-HibriChairman, Director, 10% Owner | 45,436 | $32.18 | $1,462,329 | 1,950,196 | −2.28% | plan? |
| Jun 1, 2015 PForm 4 → | Jun 2, 4:47 pm EDT | Adam HaveyEVP, Biodefense Divison | 98 | $27.08 | $2,654 | 41,444 | +0.24% | plan? |
| May 26, 2015 SForm 4 → | May 28, 3:34 pm EDT | Jerome M HauerDirector | 500 | $30.54 | $15,272 | 16,450 | −2.95% | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:52 pm EDT | Jerome M HauerDirector | 9,400 | — | — | 16,950 | — | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:49 pm EDT | Marvin L WhiteDirector | 9,400 | — | — | 30,300 | — | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:47 pm EDT | Ronald RichardDirector | 9,400 | — | — | 28,500 | — | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:46 pm EDT | John NiederhuberDirector | 9,400 | — | — | 30,300 | — | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:43 pm EDT | George A JoulwanDirector | 9,400 | — | — | 19,500 | — | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:40 pm EDT | Zsolt HarsanyiDirector | 9,400 | — | — | 28,500 | — | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:38 pm EDT | Louis W SullivanDirector | 9,400 | — | — | 28,500 | — | plan? |
| May 21, 2015 AForm 4 → | May 21, 2:33 pm EDT | Sue BaileyDirector | 9,400 | — | — | 28,500 | — | plan? |
| May 14, 2015 GForm 4 → | May 15, 12:30 pm EDT | Daniel Abdun-NabiPresident & CEO, Director | 936 | — | — | 183,869 | — | plan? |
| May 12, 2015 SForm 4 → | May 14, 11:54 am EDT | Zsolt HarsanyiDirector | 20,800 | $30.06 | $625,296 | 19,100 | −52.1% | plan? |
| May 12, 2015 MForm 4 → | May 14, 11:54 am EDT | Zsolt HarsanyiDirector | 20,800 | $12.66 | $263,280 | 21,500 | — | plan? |
| May 12, 2015 SForm 4 → | May 14, 11:50 am EDT | Sue BaileyDirector | 19,920 | $30.12 | $600,002 | 19,100 | −51.1% | plan? |
| May 12, 2015 MForm 4 → | May 14, 11:50 am EDT | Sue BaileyDirector | 19,920 | $10.04 | $199,973 | 20,540 | — | plan? |
| Mar 10, 2015 AFForm 4 → | Mar 13, 6:06 pm EDT | Fuad El-HibriChairman, Director, 10% Owner | 44,716 | $28.94 | $245,911 | 1,995,632 | — | plan? late |
| Mar 10, 2015 AFForm 4 → | Mar 12, 5:02 pm EDT | Adam HaveyEVP, Biodefense Divison | 12,911 | $28.92 | $104,070 | 41,073 | — | plan? |
| Mar 10, 2015 AFForm 4 → | Mar 12, 5:01 pm EDT | Barry LabingerEVP, Biosciences Div. | 12,356 | $29.00 | $46,226 | 36,793 | — | plan? |
| Mar 10, 2015 AFForm 4 → | Mar 12, 5:00 pm EDT | Robert KramerEVP, Corporate Services Div | 19,754 | $29.00 | $93,956 | 71,112 | — | plan? |
| Mar 10, 2015 AFForm 4 → | Mar 12, 4:59 pm EDT | Daniel Abdun-NabiPresident & CEO, Director | 67,950 | $28.93 | $600,551 | 184,805 | — | plan? |
| Mar 9, 2015 FForm 4 → | Mar 11, 2016, 3:47 pm EST | Robert KramerEVP, Corporate Services Div | 4,582 | $34.47 | $157,924 | 80,077 | — | plan? late |
| Jan 22, 2015 AForm 4 → | Jan 23, 3:09 pm EST | Jerome M HauerDirector | 7,050 | — | — | 7,550 | — | plan? |
| Jan 20, 2015 SForm 4 → | Jan 21, 4:15 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 15,325 | $27.67 | $424,085 | 1,967,910 | −0.77% | plan? |
| Jan 20, 2015 MForm 4 → | Jan 21, 4:15 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 33,333 | $7.00 | $233,331 | 1,983,235 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2015 MForm 4 → | Jan 21, 4:15 pm EST | Fuad El-HibriChairman, Director, 10% Owner | 33,333 | — | — | 0 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2016 JForm 4/A → | Aug 4, 7:38 pm EDT | Aptevo Therapeutics Inc.APVO | 40,458,698 | — | — | 0 | — | plan? |
| Jul 29, 2016 JForm 4 → | Aug 2, 5:43 pm EDT | Aptevo Therapeutics Inc.APVO | 40,459,148 | — | — | 0 | — | plan? amended |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.